Nitric oxide sensitive guanylyl cyclase activity decreases during cerebral postnatal development because of a reduction in heterodimerization

Journal of Neurochemistry

Volumn 112, Issue 2, 2010, Pages 542-551

  Haase, Nadine ^a   Haase, Tobias ^a   Seeanner, Monika ^a   Behrends, Soenke ^a  

^a TECHNICAL UNIVERSITY OF BRAUNSCHWEIG   (Germany)

Author keywords

Cerebellum; Cerebrum; Heterodimerization; Nitric oxide sensitive guanylyl cyclase

Indexed keywords

GUANYLATE CYCLASE; HEME OXYGENASE; HEMOPROTEIN; NITRIC OXIDE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN DEVELOPMENT; DIMERIZATION; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME REGULATION; ENZYME SUBUNIT; NONHUMAN; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN EXPRESSION; RAT;

ANIMALS; ANIMALS, NEWBORN; CELL LINE, TRANSFORMED; CEREBRAL CORTEX; DIMERIZATION; FREE RADICAL SCAVENGERS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GUANYLATE CYCLASE; HEME OXYGENASE (DECYCLIZING); HEMEPROTEINS; HUMANS; HYDRAZINES; IMMUNOPRECIPITATION; INSECTS; NITRIC OXIDE; NITRIC OXIDE DONORS; PHOTOSENSITIZING AGENTS; PROTOPORPHYRINS; RATS; RATS, WISTAR; RECEPTORS, CYTOPLASMIC AND NUCLEAR; TRANSFECTION;

ANIMALIA; RATTUS;

EID: 72849116780     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2009.06484.x     Document Type: Article

References (38)

1. Bamberger A. M., Koglin M., Kempfert J., Loning T., Scholz H. Behrends S. (2001) Expression and tissue localization of soluble guanylyl cyclase in the human placenta using novel antibodies directed against the alpha(2) subunit. J. Clin. Endocrinol. Metab. 86, 909 912.
2. Behrends S., Budaeus L., Kempfert J., Scholz H., Starbatty J. Vehse K. (2001) The beta 2 subunit of nitric oxide-sensitive guanylyl cyclase is developmentally regulated in rat kidney. Naunyn Schmiedebergs Arch. Pharmacol. 364, 573 576.
3. Bennett B. M., Reynolds J. N., Prusky G. T., Douglas R. M., Sutherland R. J. Thatcher G. R. (2007) Cognitive deficits in rats after forebrain cholinergic depletion are reversed by a novel NO mimetic nitrate ester. Neuropsychopharmacology 32, 505 513.
4. Bicker G. (2007) Pharmacological approaches to nitric oxide signaling during neural development of locusts and other model insects. Arch. Insect Biochem. Physiol. 64, 43 58.
5. Bidmon H. J., Starbatty J., Gorg B., Zilles K. Behrends S. (2004) Cerebral expression of the alpha2-subunit of soluble guanylyl cyclase is linked to cerebral maturation and sensory pathway refinement during postnatal development. Neurochem. Int. 45, 821 832.
6. Dawson T. M., Dawson V. L. Snyder S. H. (1992) A novel neuronal messenger molecule in brain: the free radical, nitric oxide. Ann. Neurol. 32, 297 311.
7. Ding J. D., Burette A., Nedvetsky P. I., Schmidt H. H. Weinberg R. J. (2004) Distribution of soluble guanylyl cyclase in the rat brain. J. Comp. Neurol. 472, 437 448.
8. Dioum E. M., Rutter J., Tuckerman J. R., Gonzalez G., Gilles-Gonzalez M. A. McKnight S. L. (2002) NPAS2: a gas-responsive transcription factor. Science 298, 2385 2387.
9. Garthwaite J. (2008) Concepts of neural nitric oxide-mediated transmission. Eur. J. Neurosci. 27, 2783 2802.
10. Gibb B. J. Garthwaite J. (2001) Subunits of the nitric oxide receptor, soluble guanylyl cyclase, expressed in rat brain. Eur. J. Neurosci. 13, 539 544. (Pubitemid 32158786)
11. Gibb B. J., Wykes V. Garthwaite J. (2003) Properties of NO-activated guanylyl cyclases expressed in cells. Br. J. Pharmacol. 139, 1032 1040.
12. Gupta G., Azam M., Yang L. Danziger R. S. (1997) The beta2 subunit inhibits stimulation of the alpha1beta1 form of soluble guanylyl cyclase by nitric oxide. Potential relevance to regulation of blood pressure. J. Clin. Invest. 100, 1488 1492.
13. Hernandez-Viadel M., Castoldi A. F., Coccini T., Manzo L., Erceg S. Felipo V. (2004) In vivo exposure to carbon monoxide causes delayed impairment of activation of soluble guanylate cyclase by nitric oxide in rat brain cortex and cerebellum. J. Neurochem. 89, 1157 1165.
14. Hindley S., Juurlink B. H., Gysbers J. W., Middlemiss P. J., Herman M. A. Rathbone M. P. (1997) Nitric oxide donors enhance neurotrophin-induced neurite outgrowth through a cGMP-dependent mechanism. J. Neurosci. Res. 47, 427 439.
15. Jakobs K. H., Saur W. Schultz G. (1976) Reduction of adenylate cyclase activity in lysates of human platelets by the alpha-adrenergic component of epinephrine. J. Cyclic Nucleotide Res. 2, 381 392.
16. Koglin M. Behrends S. (2003) A functional domain of the alpha1 subunit of soluble guanylyl cyclase is necessary for activation of the enzyme by nitric oxide and YC-1 but is not involved in heme binding. J. Biol. Chem. 278, 12590 12597.
17. Koglin M., Vehse K., Budaeus L., Scholz H. Behrends S. (2001) Nitric oxide activates the beta 2 subunit of soluble guanylyl cyclase in the absence of a second subunit. J. Biol. Chem. 276, 30737 30743.
18. Lu Y. F., Kandel E. R. Hawkins R. D. (1999) Nitric oxide signaling contributes to late-phase LTP and CREB phosphorylation in the hippocampus. J. Neurosci. 19, 10250 10261.
19. Morrison G. R. (1965) Fluorometric microdetermination of heme protein. Anal. Chem. 37, 1124 1126.
20. Nedvetsky P. I., Kleinschnitz C. Schmidt H. H. (2002) Regional distribution of protein and activity of the nitric oxide receptor, soluble guanylyl cyclase, in rat brain suggests multiple mechanisms of regulation. Brain Res. 950, 148 154.
21. Polleux F., Morrow T. Ghosh A. (2000) Semaphorin 3A is a chemoattractant for cortical apical dendrites. Nature 404, 567 573.
22. Puzzo D., Vitolo O., Trinchese F., Jacob J. P., Palmeri A. Arancio O. (2005) Amyloid-beta peptide inhibits activation of the nitric oxidecGMPcAMP-responsive element-binding protein pathway during hippocampal synaptic plasticity. J. Neurosci. 25, 6887 6897.
23. Roy B., Mo E., Vernon J. Garthwaite J. (2008) Probing the presence of the ligand-binding haem in cellular nitric oxide receptors. Br. J. Pharmacol. 153, 1495 1504.
24. Russwurm M., Behrends S., Harteneck C. Koesling D. (1998) Functional properties of a naturally occurring isoform of soluble guanylyl cyclase. Biochem. J. 335 (Pt 1 125 130.
25. Russwurm M., Wittau N. Koesling D. (2001) Guanylyl cyclasePSD-95 interaction: targeting of the nitric oxide-sensitive alpha2beta1 guanylyl cyclase to synaptic membranes. J. Biol. Chem. 276, 44647 44652.
26. Schindler U., Strobel H., Schonafinger K. et al. (2006) Biochemistry and pharmacology of novel anthranilic acid derivatives activating heme-oxidized soluble guanylyl cyclase. Mol. Pharmacol. 69, 1260 1268.
27. Schwarz D., Kisselev P., Honeck H., Cascorbi I., Schunck W. H. Roots I. (2001) Co-expression of human cytochrome P4501A1 (CYP1A1) variants and human NADPH-cytochrome P450 reductase in the baculovirusinsect cell system. Xenobiotica 31, 345 356.
28. Son H., Lu Y. F., Zhuo M., Arancio O., Kandel E. R. Hawkins R. D. (1998) The specific role of cGMP in hippocampal LTP. Learn. Mem. 5, 231 245.
29. Stasch J. P., Schmidt P., Alonso-Alija C. et al. (2002) NO- and haem-independent activation of soluble guanylyl cyclase: molecular basis and cardiovascular implications of a new pharmacological principle. Br. J. Pharmacol. 136, 773 783.
30. Stasch J. P., Schmidt P. M., Nedvetsky P. I. et al. (2006) Targeting the heme-oxidized nitric oxide receptor for selective vasodilatation of diseased blood vessels. J. Clin. Invest. 116, 2552 2561.
31. Sun Y., Rotenberg M. O. Maines M. D. (1990) Developmental expression of heme oxygenase isozymes in rat brain. Two HO-2 mRNAs are detected. J. Biol. Chem. 265, 8212 8217.
32. Taqatqeh F., Mergia E., Neitz A., Eysel U. T., Koesling D. Mittmann T. (2009) More than a retrograde messenger: nitric oxide needs two cGMP pathways to induce hippocampal long-term potentiation. J. Neurosci. 29, 9344 9350.
33. Thatcher G. R., Bennett B. M. Reynolds J. N. (2005) Nitric oxide mimetic molecules as therapeutic agents in Alzheimer's disease. Curr. Alzheimer Res. 2, 171 182.
34. Thatcher G. R., Bennett B. M. Reynolds J. N. (2006) NO chimeras as therapeutic agents in Alzheimer's disease. Curr. Alzheimer Res. 3, 237 245.
35. Wang X. Robinson P. J. (1997) Cyclic GMP-dependent protein kinase and cellular signaling in the nervous system. J. Neurochem. 68, 443 456.
36. Yuen P. S., Potter L. R. Garbers D. L. (1990) A new form of guanylyl cyclase is preferentially expressed in rat kidney. Biochemistry 29, 10872 10878.
37. Zabel U., Hausler C., Weeger M. Schmidt H. H. (1999) Homodimerization of soluble guanylyl cyclase subunits. Dimerization analysis using a glutathione s-transferase affinity tag. J. Biol. Chem. 274, 18149 18152.
38. Zabel U., Kleinschnitz C., Oh P. et al. (2002) Calcium-dependent membrane association sensitizes soluble guanylyl cyclase to nitric oxide. Nat. Cell Biol. 4, 307 311. (Pubitemid 34308857)